STAT+: Pharmalittle: We’re reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more

Excerpt from STAT News.

More Stories

Lifestyle

I’m a Chef on a GLP-1. I Believe the Future of Food Is About to Change Dramatically.

”I don’t want less pleasure. I want less eating that isn’t actually giving me pleasure.”

🇺🇸 Mens Health 49m ago

Lifestyle

STAT+: Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO

A targeted drug from Incyte, when used in combination with chemotherapy, induced lasting tumor responses in certain pati…

🇺🇸 STAT News 1h ago

Lifestyle

STAT+: Five biotech updates to read after ESMO this weekend

Moderna and Merck are racing to submit their personalized cancer vaccine for FDA approval, expected in 2027, according t…

🇺🇸 STAT News 1h ago